Differential survival in blacks and Hispanics with AIDS. NLM AIDSLINE Important note: Information in this article was accurate in 1998. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Differential survival in blacks and Hispanics with AIDS.

Ethn Health. 1996 Dec;1(4):373-82. Unique Identifier : AIDSLINE MED/98051763
Murrain M; School of Natural Science, Hampshire College, Amhurst, MA 01002, USA.

Abstract: OBJECTIVE: The object of this study was to investigate whether there are differences in survival by ethnicity in people with AIDS. DESIGN: The CDC Public Access Dataset was analysed. To estimate survival more accurately, a cohort of individuals diagnosed in 1987 was chosen from the dataset. Using this analysis, probabilities of survival were estimated. RESULTS: There were significant differences in survival in blacks and Hispanics as compared to whites diagnosed in 1987. Although there are differences in survival by transmission category, survival differences by ethnicity persisted when analysed within specific transmission categories. A model where the frequency distributions of survival were log-transformed suggests that disease progression per se may not be the most important factor, but time of diagnosis may be. In addition, in looking at median survival by year of diagnosis, it is clear that blacks and Hispanics have not shown the same magnitude of improvement in survival time, and lag behind whites. CONCLUSIONS: This study clearly shows differences in survival with AIDS by ethnicity. Differential access to health care may underlie such ethnic differences in survival.
Keywords: *Acquired Immunodeficiency Syndrome/ETHNOLOGY *Acquired Immunodeficiency Syndrome/MORTALITY *Blacks *Hispanic AmericansKWDacquiredimmunodeficiencysyndrome/ethnologyKWDacquiredimmunodeficiencysyndrome/mortalityKWDblacksKWDhispanicamericans
980330
M9831202

Copyright © 1998 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1998. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1998. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .